--- title: Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY nct_id: NCT01467557 overall_status: COMPLETED sponsor: Johnson & Johnson Vision Care, Inc. study_type: OBSERVATIONAL primary_condition: Myopia countries: United States canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01467557.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01467557" ct_last_update_post_date: 2018-06-19 last_seen_at: "2026-05-12T06:28:50.585Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY **Official Title:** 1•DAY ACUVUE® TruEye™ Brand Contact Lenses & 1•DAY ACUVUE® MOIST® Brand Contact Lenses With LACREON® TECHNOLOGY Daily Disposable Performance Overview Registry -TEMPO Study **NCT ID:** [NCT01467557](https://clinicaltrials.gov/study/NCT01467557) ## Key Facts - **Status:** COMPLETED - **Study Type:** OBSERVATIONAL - **Target Enrollment:** 1171 - **Lead Sponsor:** Johnson & Johnson Vision Care, Inc. - **Conditions:** Myopia, Hyperopia - **Start Date:** 2011-10 - **Completion Date:** 2013-10 - **CT.gov Last Update:** 2018-06-19 ## Brief Summary This study is an observational registry of patients who have recently been prescribed 1•DAY ACUVUE® TruEye® or 1•DAY ACUVUE® MOIST® Brand Contact Lenses with LACREON® TECHNOLOGY. ## Eligibility - **Minimum age:** 8 Years - **Sex:** ALL - **Healthy Volunteers:** No ``` Inclusion Criteria: * Wearers of 1•DAY ACUVUE® TruEye™ or 1•DAY ACUVUE® MOIST® daily disposable soft contact lenses in both eyes aged \>8 years of age who have recently begun use of that lens type and have purchased at least 3 month supply of lenses. * The registrant must read and sign the Informed Consent form. Minor subjects must obtain parental signature of Informed Consent and also sign an Informed Assent Form. * The registrant must sign the Release of Medical Records in the event of an adverse event in the study. * The registrant must appear able and willing to adhere to the instructions set forth in this clinical protocol. Exclusion Criteria: * Previously wearing the type of lenses with which they are registering (1•DAY ACUVUE® TruEye™ or 1•DAY ACUVUE® MOIST® Daily Disposable lenses). * Current participant in an unrelated research study. * Employee or family member of Recruiting Practitioner or Johnson \& Johnson. ``` ## Arms - **1-Day ACUVUE TruEye contact lens users** — 1-Day ACUVUE TruEye contact lens users - **1-Day ACUVUE MOIST contact lens users** — 1-Day ACUVUE MOIST contact lens users ## Interventions - **narafilcon B daily disposable soft contact lenses** (DEVICE) — daily disposable soft contact lenses - **etafilcon A daily disposable soft contact lenses** (DEVICE) — daily disposable soft contact lenses ## Primary Outcomes - **Incidence of Adverse Events** _(time frame: Self-report at 2 Week, 4 Month or 12 Month surveys)_ — Adverse events were reported by subjects via the electronic surveys if they responded "yes" to the question "Since we last contacted you, have you experienced a red or painful eye that required a visit to an eye doctor or emergency room?". Consensus diagnosis was made after review of clinical records by Adjudication Panel. ## Secondary Outcomes - **Change in 8-item Contact Lens Dry Eye Questionnaire Score From Baseline to 2 Week, 4 Month and 12 Month Surveys** _(time frame: Baseline, 2 Week, 4 Month or 12 Month surveys)_ ## Locations (37) - Campbell, California, United States - Fullerton, California, United States - Huntington Beach, California, United States - Los Angeles, California, United States - Mountain View, California, United States - Newport Beach, California, United States - Salinas, California, United States - San Francisco, California, United States - San Francisco, California, United States - San Francisco, California, United States - San Jose, California, United States - Sunnyvale, California, United States - Washington D.C., District of Columbia, United States - Boca Raton, Florida, United States - Boca Raton, Florida, United States - Fort Lauderdale, Florida, United States - Fort Lauderdale, Florida, United States - North Miami, Florida, United States - Pembroke Pines, Florida, United States - Wellington, Florida, United States - Roswell, Georgia, United States - Des Moines, Iowa, United States - Shreveport, Louisiana, United States - Belmont, Massachusetts, United States - Cambridge, Massachusetts, United States - Dedham, Massachusetts, United States - Lake Hopatcong, New Jersey, United States - New York, New York, United States - New York, New York, United States - Charlotte, North Carolina, United States - Gastonia, North Carolina, United States - Cleveland, Ohio, United States - Johnstown, Ohio, United States - Westerville, Ohio, United States - Brentwood, Tennessee, United States - Amarillo, Texas, United States - Milwaukee, Wisconsin, United States ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `outcomes.secondary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ - `locations.|campbell|california|united states` — added _(2026-05-12)_ - `locations.|fullerton|california|united states` — added _(2026-05-12)_ - `locations.|huntington beach|california|united states` — added _(2026-05-12)_ - `locations.|los angeles|california|united states` — added _(2026-05-12)_ - `locations.|mountain view|california|united states` — added _(2026-05-12)_ - `locations.|newport beach|california|united states` — added _(2026-05-12)_ - `locations.|salinas|california|united states` — added _(2026-05-12)_ - `locations.|san francisco|california|united states` — added _(2026-05-12)_ - `locations.|san jose|california|united states` — added _(2026-05-12)_ - `locations.|sunnyvale|california|united states` — added _(2026-05-12)_ - `locations.|washington d.c.|district of columbia|united states` — added _(2026-05-12)_ - `locations.|boca raton|florida|united states` — added _(2026-05-12)_ - `locations.|fort lauderdale|florida|united states` — added _(2026-05-12)_ - `locations.|north miami|florida|united states` — added _(2026-05-12)_ - `locations.|pembroke pines|florida|united states` — added _(2026-05-12)_ - `locations.|wellington|florida|united states` — added _(2026-05-12)_ - `locations.|roswell|georgia|united states` — added _(2026-05-12)_ - `locations.|des moines|iowa|united states` — added _(2026-05-12)_ - `locations.|shreveport|louisiana|united states` — added _(2026-05-12)_ - `locations.|belmont|massachusetts|united states` — added _(2026-05-12)_ - `locations.|cambridge|massachusetts|united states` — added _(2026-05-12)_ - `locations.|dedham|massachusetts|united states` — added _(2026-05-12)_ - `locations.|lake hopatcong|new jersey|united states` — added _(2026-05-12)_ - `locations.|new york|new york|united states` — added _(2026-05-12)_ - `locations.|charlotte|north carolina|united states` — added _(2026-05-12)_ - `locations.|gastonia|north carolina|united states` — added _(2026-05-12)_ - `locations.|cleveland|ohio|united states` — added _(2026-05-12)_ - `locations.|johnstown|ohio|united states` — added _(2026-05-12)_ - `locations.|westerville|ohio|united states` — added _(2026-05-12)_ - `locations.|brentwood|tennessee|united states` — added _(2026-05-12)_ - `locations.|amarillo|texas|united states` — added _(2026-05-12)_ - `locations.|milwaukee|wisconsin|united states` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT01467557.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT01467557* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*